FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jamie Findlow

Research Profile

Chemicals & Drugs

Disorders

Meningococcal Infections

Living Beings

Geographic Areas

England

Physiology

Procedures

Co-author Network

Publications

TOP 3
E T Clarke; P M Dull; Jamie Findlow; A Finn; R Borrow; Neil A Williams; R S Heyderman
Polysaccharide-protein conjugate vaccination induces antibody production but not sustained B-cell memory in the human nasopharyngeal mucosa.
David A Ishola; Ray Borrow; Helen Findlow; Jamie Findlow; Caroline Trotter; Mary E Ramsay
Prevalence of serum bactericidal antibody to serogroup C Neisseria meningitidis in England a decade after vaccine introduction.
Helen Findlow; Jamie Findlow; David Goldblatt; Mary Matheson; Nick Andrews; Lindsey Ashton; Ray Borrow; Anna England; Elizabeth Sheasby; Pauline Waight; Elizabeth Miller
Immunogenicity of a single dose of meningococcal group C conjugate vaccine given at 3 months of age to healthy infants in the United kingdom.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jamie Findlow (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: E T Clarke; P M Dull; Jamie Findlow; A Finn; R Borrow; Neil A Williams; R S Heyderman
Polysaccharide-protein conjugate vaccination induces antibody production but not sustained B-cell memory in the human nasopharyngeal mucosa.
Mucosal immunology 2013;6(2):288-96.
2012: David A Ishola; Ray Borrow; Helen Findlow; Jamie Findlow; Caroline Trotter; Mary E Ramsay
Prevalence of serum bactericidal antibody to serogroup C Neisseria meningitidis in England a decade after vaccine introduction.
Clinical and vaccine immunology : CVI 2012;19(8):1126-30.
2012: Helen Findlow; Jamie Findlow; David Goldblatt; Mary Matheson; Nick Andrews; Lindsey Ashton; Ray Borrow; Anna England; Elizabeth Sheasby; Pauline Waight; Elizabeth Miller
Immunogenicity of a single dose of meningococcal group C conjugate vaccine given at 3 months of age to healthy infants in the United kingdom.
The Pediatric infectious disease journal 2012;31(6):616-22.
2012: Jane Astrid Metz; David Roger Murdoch; Omar Omar; Rahul Pradhan; Disuja Shakya; Amrita Shrestha; Lochan Shrestha; Stephen Mark Thorson; Bishwas Upadhyay; Ly-Mee Yu; Neelam Adhikari; Raymond Borrow; Jamie Findlow; Sarah Hanieh; Tessa M John; Anip Joshi; Dominic F Kelly; Sarah C Kelly; Bishnu Devi Maharjan; Andrew John Pollard
Evaluation of haemophilus influenzae type b vaccine for routine immunization in Nepali infants.
The Pediatric infectious disease journal 2012;31(4):e66-72.
2012: Sn Ladhani; G Laher; S Martin; Sy Min; E Newton; R Pebody; Me Ramsay; Mp Slack; R Warrington; M Wilding; H Campbell; H Crawford; Jamie Findlow; Js Flood; S Frankland; K Gray; N Bokuvha; R Borrow
Haemophilus influenzae serotype B (Hib) seroprevalence in England and Wales in 2009.
Euro surveillance : bulletin Européen sur les maladies transmissibles = European communicable disease bulletin 2012;17(46):.
2012: James B Wing; Jennifer Carlring; Rachel A Foster; Andrew Lees; Robert C Read; Lynne Smart; Ray Borrow; Helen Findlow; Jamie Findlow; Andrew W Heath
Correlation of group C meningococcal conjugate vaccine response with B- and T-lymphocyte activity.
PloS one 2012;7(2):e31160.
2012: Shamez N Ladhani; Jay Lucidarme; Lynne S Newbold; Mary E Ramsay; Anthony D Carr; Jamie Findlow; Stephen J Gray; Edward B Kaczmarski; Raymond Borrow
Invasive meningococcal capsular group Y disease, England and Wales, 2007-2009.
Emerging infectious diseases 2012;18(1):63-70.
2011: Xilian Bai; Jamie Findlow; Ray Borrow
Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles.
Expert opinion on biological therapy 2011;11(7):969-85.
2011: Jay Lucidarme; Lionel Tan; Rachel M Exley; Jamie Findlow; Ray Borrow; Christoph M Tang
Characterization of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen factor H binding protein.
Clinical and vaccine immunology : CVI 2011;18(6):1002-14.
2011: Jay Lucidarme; Lynne S Newbold; Jamie Findlow; Stefanie Gilchrist; Stephen J Gray; Anthony D Carr; James Hewitt; Edward B Kaczmarski; Ray Borrow
Molecular targets in meningococci: efficient routine characterization and optimal outbreak investigation in conjunction with routine surveillance of the meningococcal group B vaccine candidate, fHBP.
Clinical and vaccine immunology : CVI 2011;18(2):194-202.
2010: Jamie Findlow; Ray Borrow; Matthew D Snape; Tom Dawson; Ann Holland; Tessa M John; Anita Evans; Karen L Telford; Ellen Ypma; Daniela Toneatto; Philipp Oster; Elizabeth Miller; Andrew J Pollard
Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;51(10):1127-37.
2010: Jay Lucidarme; Maurizio Comanducci; Jamie Findlow; Stephen J Gray; Edward B Kaczmarski; Malcolm Guiver; Pamela J Vallely; Philipp Oster; Mariagrazia Pizza; Stefania Bambini; Alessandro Muzzi; Ray Borrow
Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine.
Clinical and vaccine immunology : CVI 2010;17(6):919-29.
2010: Ray Borrow; Nick Andrews; Helen Findlow; Pauline Waight; Jo Southern; Annette Crowley-Luke; Lorraine Stapley; Anna England; Jamie Findlow; Elizabeth Miller
Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine.
Clinical and vaccine immunology : CVI 2010;17(1):154-9.
2009: Jay Lucidarme; Maurizio Comanducci; Jamie Findlow; Stephen J Gray; Edward B Kaczmarski; Malcolm Guiver; Elisabeth Kugelberg; Pamela J Vallely; Philipp Oster; Mariagrazia Pizza; Stefania Bambini; Alessandro Muzzi; Christoph M Tang; Ray Borrow
Characterization of fHbp, nhba (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and Wales.
Journal of clinical microbiology 2009;47(11):3577-85.
2009: Ray Borrow; Jamie Findlow
Prevention of meningococcal serogroup C disease by NeisVac-C.
Expert review of vaccines 2009;8(3):265-79.
2009: Jo Southern; Ray Borrow; Nick Andrews; Rhonwen Morris; Pauline Waight; Michael Hudson; Paul Balmer; Helen Findlow; Jamie Findlow; Elizabeth Miller
Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United Kingdom.
Clinical and vaccine immunology : CVI 2009;16(2):194-9.
2008: Caroline L Trotter; Ray Borrow; Jamie Findlow; Ann Holland; Sarah Frankland; Nick J Andrews; Elizabeth Miller
Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination era.
Clinical and vaccine immunology : CVI 2008;15(11):1694-8.
2008: Victoria Davenport; Eleanor Groves; Rachel E Horton; C G L Hobbs; Terry Guthrie; Jamie Findlow; Ray Borrow; Lisbeth M Naess; Philipp Oster; Robert S Heyderman; Neil A Williams
Mucosal immunity in healthy adults after parenteral vaccination with outer-membrane vesicles from Neisseria meningitidis serogroup B.
The Journal of infectious diseases 2008;198(5):731-40.
2007: Jamie Findlow; Ann Holland; Nick Andrews; Vincent E Weynants; Franklin Sotolongo; Paul Balmer; Jan Poolman; Ray Borrow
Comparison of phenotypically indistinguishable but geographically distinct Neisseria meningitidis Group B isolates in a serum bactericidal antibody assay.
Clinical and vaccine immunology : CVI 2007;14(11):1451-7.
2007: Paul Balmer; Ray Borrow; Jamie Findlow; Rosalind Warrington; Sarah Frankland; Pauline Waight; Robert George; Nick Andrews; Elizabeth Miller
Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vaccine.
Clinical and vaccine immunology : CVI 2007;14(11):1442-50.
2007: Rolando Pajon Feyt; Olivia Niebla; Daniel Yero; Oliver Pérez; Osmir Cabrera; Jamie Findlow; Paul Balmer; Ray Borrow
On the neisserial vaccine quest: Neisseria Vaccines 2007.
Expert review of anti-infective therapy 2007;5(4):545-50.
2007: Jamie Findlow; Paul Balmer; Daniel Yero; Olivia Niebla; Rolando Pajon Feyt; Ray Borrow
Neisseria vaccines 2007.
Expert review of vaccines 2007;6(4):485-9.
2007: Caroline Trotter; Jamie Findlow; Paul Balmer; Ann Holland; Rita Barchha; Nick Hamer; Nick Andrews; Elizabeth Miller; Ray Borrow
Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in England.
Clinical and vaccine immunology : CVI 2007;14(7):863-8.
2007: Jamie Findlow; Ann Holland; Diana Martin; Philipp Oster; Paul Balmer; Ray Borrow
Inadequacy of colominic acid as an absorbent intended to facilitate use of complement-preserved baby rabbit serum in the Neisseria meningitidis serogroup B serum bactericidal antibody assay.
Clinical and vaccine immunology : CVI 2007;14(5):556-61.
2007: Dominique Boutriau; Jan Poolman; Ray Borrow; Jamie Findlow; Javier Diez Domingo; Joan Puig-Barberà; José María Baldó; Victoria Planelles; Angels Jubert; Julia Colomer; Angel Gil; Karin Levie; Anne-Diane Kervyn; Vincent E Weynants; Francisco Dominguez; Ramón Barberá; Franklin Sotolongo
Immunogenicity and safety of three doses of a bivalent (B:4:p1.19,15 and B:4:p1.7-2,4) meningococcal outer membrane vesicle vaccine in healthy adolescents.
Clinical and vaccine immunology : CVI 2007;14(1):65-73.
2006: Jamie Findlow; Stephen Taylor; Audun Aase; Rachel Horton; Robert S Heyderman; Jo Southern; Nick Andrews; Rita Barchha; Ewan Harrison; Ann Lowe; Emma Boxer; Charlotte Heaton; Paul Balmer; Edward B Kaczmarski; Philipp Oster; Andrew R Gorringe; Ray Borrow; Elizabeth Miller
Comparison and correlation of neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac.
Infection and immunity 2006;74(8):4557-65.
2005: Ray Borrow; Ingeborg S Aaberge; George F Santos; T Lynn Eudey; Philipp Oster; Anne Glennie; Jamie Findlow; E Arne Høiby; Einar Rosenqvist; Paul Balmer; Diana Martin
Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup b, strain 44/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine.
Clinical and diagnostic laboratory immunology 2005;12(8):970-6.
2005: Jamie Findlow; Ann Lowe; Sarah Deane; Paul Balmer; Germie van den Dobbelsteen; Maureen Dawson; Nick Andrews; Ray Borrow
Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine in toddlers and school children.
Vaccine 2005;23(20):2623-7.
2003: Victoria Davenport; Terry Guthrie; Jamie Findlow; Ray Borrow; Neil A Williams; Robert S Heyderman
Evidence for naturally acquired T cell-mediated mucosal immunity to Neisseria meningitidis.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(8):4263-70.
2002: Moya Burrage; Andrew Robinson; Ray Borrow; Nick Andrews; Jo Southern; Jamie Findlow; Sarah Martin; Carol Thornton; David Goldblatt; Michael J Corbel; Dorothea Sesardic; Keith Cartwight; Peter Richmond; Elizabeth Miller
Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection.
Infection and immunity 2002;70(9):4946-54.
2001: Peter Richmond; Ray Borrow; Jamie Findlow; Sarah Martin; Carol Thornton; Keith Cartwright; Elizabeth Miller
Evaluation of De-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and De-O-acetylated serogroup C strains.
Infection and immunity 2001;69(4):2378-82.
2001: Peter Richmond; Ray Borrow; David Goldblatt; Jamie Findlow; Sarah Martin; Rhonwen Morris; Keith Cartwright; Elizabeth Miller
Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers.
The Journal of infectious diseases 2001;183(1):160-3.
2000: Ray Borrow; Peter Richmond; Edward B Kaczmarski; A Iverson; S L Martin; Jamie Findlow; M Acuna; Emma Longworth; R O'Connor; J Paul; Elizabeth Miller
Meningococcal serogroup C-specific IgG antibody responses and serum bactericidal titres in children following vaccination with a meningococcal A/C polysaccharide vaccine.
FEMS immunology and medical microbiology 2000;28(1):79-85.
2000: Peter Richmond; Edward B Kaczmarski; Ray Borrow; Jamie Findlow; S Clark; R McCann; J Hill; M Barker; Elizabeth Miller
Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine.
The Journal of infectious diseases 2000;181(2):761-4.